Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com
A02259 | Pages: NA | Charts: NA | Tables: NA |
Wound care therapy includes medications and equipment required to treat various injuries including lacerations, pressure ulcers, or deep burn injuries. Developments in the wound dressings sector have reduced the number of amputations and permanent disabilities caused due to injuries or infections.
The global wound dressings market is driven by increase in geriatric population who are prone to surgeries and avail wound care therapies, high number of road accidents, increase in in the number of patients with diabetic wounds due to sedentary lifestyle, and increase in incidence of chronic infections. However, high cost of advanced wound care products and limited reimbursement policies in the developing countries restrain the market growth. Conversely, large number of upcoming surgeries, growth in awareness about wound care dressings, and various advancements in products, such silver wound dressings, present lucrative growth opportunities for the market.
The global wound dressings market is segmented on the basis of product, application, end user, and geography. Based on product, it is bifurcated into traditional wound dressings and advanced wound dressings. Based on the application, it is divided into surgical wounds, pressure ulcers, venous ulcers, diabetic foot ulcers, and burns. Based on the end user, it is classified into inpatient facilities and outpatient facilities. Geographically, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The major key players operating in this market include Coloplast A/S, ConvaTec Healthcare B S. r.l., Smith & Nephew plc., Aspen Insurance Holdings Limited, C. R. Bard, Inc., B. Braun Group, Cardinal Health, Inc., Medtronic plc., Acelity L.P. Inc., and Organogenesis Inc.
Key Benefits
Key Market Segments
Key Market Players